Rochester, MN — Mayo Clinic Platform_Accelerate celebrated the graduation of its fourth cohort of health tech startups, including nine innovative businesses from around the world. During the graduation event, held March 28 in Eagan, Minnesota, each company presented progress and outcomes from the 20-week accelerator program, providing a glimpse into the future of medicine.

"It's with immense pride that we celebrate the nine graduate companies from our latest cohort. Their remarkable dedication, resilience and achievements have truly set a new standard. We are excited to keep championing their journey as they advance patient care globally," says Jamie Sundsbak, senior manager of the Accelerate program.

Using Mayo Clinic Platform's global, de-identified data network, Mayo Clinic Platform_Accelerate helps startups focus on validation and clinical readiness of their artificial intelligence-driven solutions in line with healthcare industry standards. The program provides participants access to Mayo Clinic experts in regulatory, clinical, technology and business domains. As part of this in-kind investment, Mayo Clinic Platform has an equity position in the companies.

Learn more about the members of Cohort 4:

• ArtiMed is developing AI-based risk stratification software-as-a-service (SaaS) tools. These tools are designed to assist health plans and insurers to manage the challenges presented by patients with major chronic and acute conditions within their populations. Additionally, they enable pharmaceutical companies in identifying individuals who might benefit from their drugs for these conditions.

This press release was originally posted by Mayo Clinic on their website.